RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network

Kyeongkyu Kim(Seoul National University), Kyung-Jin Boo(Seoul National University), Young Suk Yu(Seoul National University), Se Kyu Oh(Seoul National University), Hyun-Kyung Kim(Seoul National University), Yoon Jeon(National Cancer Center), Jinhyuk Bhin(Daegu Gyeongbuk Institute of Science and Technology), Daehee Hwang(Daegu Gyeongbuk Institute of Science and Technology), Keun Il Kim(Seoul National University), Jun-Su Lee(Keimyung University), Seung‐Soon Im(Keimyung University), Seul Gi Yoon(Seoul National University), Il Yong Kim(Seoul National University), Je Kyung Seong(Seoul National University), Ho Lee(National Cancer Center), Sungsoon Fang(Yonsei University), Sung Hee Baek(Seoul National University)
Nature Communications
July 24, 2017
Cited by 144Open Access
Full Text

Abstract

The retinoic acid receptor-related orphan receptor-α (RORα) is an important regulator of various biological processes, including cerebellum development, circadian rhythm and cancer. Here, we show that hepatic RORα controls lipid homeostasis by negatively regulating transcriptional activity of peroxisome proliferators-activated receptor-γ (PPARγ) that mediates hepatic lipid metabolism. Liver-specific Rorα-deficient mice develop hepatic steatosis, obesity and insulin resistance when challenged with a high-fat diet (HFD). Global transcriptome analysis reveals that liver-specific deletion of Rorα leads to the dysregulation of PPARγ signaling and increases hepatic glucose and lipid metabolism. RORα specifically binds and recruits histone deacetylase 3 (HDAC3) to PPARγ target promoters for the transcriptional repression of PPARγ. PPARγ antagonism restores metabolic homeostasis in HFD-fed liver-specific Rorα deficient mice. Our data indicate that RORα has a pivotal role in the regulation of hepatic lipid homeostasis. Therapeutic strategies designed to modulate RORα activity may be beneficial for the treatment of metabolic disorders.Hepatic steatosis development may result from dysregulation of lipid metabolism, which is finely tuned by several transcription factors including the PPAR family. Here Kim et al. show that the nuclear receptor RORα inhibits PPARγ-mediated transcriptional activity by interacting with HDAC3 and competing for the promoters of lipogenic genes.


Related Papers

No related papers found

Powered by citation graph analysis